Institute: International Vaccine Institute (IVI)
Biography
My main scientific achievement has been the development of the novel recombinant CYD-TDV dengue vaccine from the phase 1 to the phase 4 studies after having been involved in the disease burden assessment in Asia. I have experience in conducting clinical trials in Asia (i.e., LMICs and developed countries). My main research interests are on vaccines with viral, bacteria, and parasites and I have been involved in the design conduct of pre and post-licensure studies.
Key Publications
A list of publications can be found here.
Web Links of Interest